US Patent 9409974 Immunogenic composition
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+225 characters)
Article
Patent abstract
The present invention relates to fusion proteins comprising fragments from toxin A and/or toxin B of Clostridium difficile, wherein the polypeptide elicits antibodies that neutralize toxin A or toxin B or both.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Cindy Castado0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09409974 Immunogenic composition US Patent 9409974 Immunogenic composition
Infobox
Patent Number
094099740
Patent Number
94099740
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
094099740
Date of Patent
August 9, 2016
0Patent Application Number
141223450
Date Filed
May 25, 2012
0Official Website
Patent Primary Examiner
Edits on 5 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09409974 Immunogenic composition
Infobox
Is a
Patent jurisdiction
Patent number
09409974
Date of patent
August 9, 2016
Patent application number
14122345
Date Filed
May 25, 2012
Patent primary examiner
Find more entities like US Patent 9409974 Immunogenic composition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
